» Articles » PMID: 18575631

The M235T Polymorphism in the AGT Gene and CHD Risk: Evidence of a Hardy-Weinberg Equilibrium Violation and Publication Bias in a Meta-analysis

Overview
Journal PLoS One
Date 2008 Jun 26
PMID 18575631
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The M235T polymorphism in the AGT gene has been related to an increased risk of hypertension. This finding may also suggest an increased risk of coronary heart disease (CHD).

Methodology/principal Findings: A case-cohort study was conducted in 1,732 unrelated middle-age women (210 CHD cases and 1,522 controls) from a prospective cohort of 15,236 initially healthy Dutch women. We applied a Cox proportional hazards model to study the association of the polymorphism with acute myocardial infarction (AMI) (n = 71) and CHD. In the case-cohort study, no increased risk for CHD was found under the additive genetic model (hazard ratio [HR] = 1.20; 95% confidence interval [CI], 0.86 to 1.68; P = 0.28). This result was not changed by adjustment (HR = 1.17; 95% CI, 0.83 to 1.64; P = 0.38) nor by using dominant, recessive and pairwise genetic models. Analyses for AMI risk under the additive genetic model also did not show any statistically significant association (crude HR = 1.14; 95% CI, 0.93 to 1.39; P = 0.20). To evaluate the association, a comprehensive systematic review and meta-analysis were undertaken of all studies published up to February 2007 (searched through PubMed/MEDLINE, Web of Science and EMBASE). The meta-analysis (38 studies with 13284 cases and 18722 controls) showed a per-allele odds ratio (OR) of 1.08 (95% CI, 1.01 to 1.15; P = 0.02). Moderate to large levels of heterogeneity were identified between studies. Hardy-Weinberg equilibrium (HWE) violation and the mean age of cases were statistically significant sources of the observed variation. In a stratum of non-HWE violation studies, there was no effect. An asymmetric funnel plot, the Egger's test (P = 0.066), and the Begg-Mazumdar test (P = 0.074) were all suggestive of the presence of publication bias.

Conclusions/significance: The pooled OR of the present meta-analysis, including our own data, presented evidence that there is an increase in the risk of CHD conferred by the M235T variant of the AGT gene. However, the relevance of this weakly positive overall association remains uncertain because it may be due to various residual biases, including HWE-violation and publication biases.

Citing Articles

Genetic Polymorphism in Angiotensinogen and Its Association with Cardiometabolic Diseases.

Shahid M, Rehman K, Akash M, Suhail S, Kamal S, Imran M Metabolites. 2022; 12(12).

PMID: 36557328 PMC: 9785123. DOI: 10.3390/metabo12121291.


Case-Control Study on the Interaction Effects of rs10757278 Polymorphisms at 9p21 Locus and Traditional Risk Factors on Coronary Heart Disease in Xinjiang, China.

Lu W, Zhang W, Zhao Y, Gao Y, Tao N, Ma Y J Cardiovasc Pharmacol. 2020; 75(5):439-445.

PMID: 32079855 PMC: 7249490. DOI: 10.1097/FJC.0000000000000807.


Does hypermethylation of CpG island in the promoter region of the E-cadherin gene increase the risk of lung cancer? A meta-analysis.

Sun Z, Liu G, Xu N Thorac Cancer. 2018; 10(1):54-59.

PMID: 30390382 PMC: 6312839. DOI: 10.1111/1759-7714.12900.


Associations of the A66G Methionine Synthase Reductase Polymorphism in Colorectal Cancer: A Systematic Review and Meta-Analysis.

Pabalan N, Singian E, Tabangay L, Jarjanazi H, Singh N Biomark Cancer. 2015; 7(Suppl 1):21-8.

PMID: 26549973 PMC: 4627415. DOI: 10.4137/BIC.S25251.


Associations of the Insertion/Deletion Polymorphism in the ACE Gene and Risk of Gastric Cancer: A Meta-Analysis.

Pabalan N, Jarjanazi H, Ozcelik H J Gastrointest Cancer. 2015; 46(4):370-9.

PMID: 26307111 DOI: 10.1007/s12029-015-9754-8.


References
1.
Sheu W, Lee W, Jeng C, Young M, Ding Y, Chen Y . Angiotensinogen gene polymorphism is associated with insulin resistance in nondiabetic men with or without coronary heart disease. Am Heart J. 1998; 136(1):125-31. DOI: 10.1016/s0002-8703(98)70192-9. View

2.
Nair K, Shalia K, Ashavaid T, Dalal J . Coronary heart disease, hypertension, and angiotensinogen gene variants in Indian population. J Clin Lab Anal. 2003; 17(5):141-6. PMC: 6807782. DOI: 10.1002/jcla.10084. View

3.
Batalla A, Alvarez R, Reguero J, Hevia S, Alvarez V, Cortina A . Synergistic effect between apolipoprotein E and angiotensinogen gene polymorphisms in the risk for early myocardial infarction. Clin Chem. 2000; 46(12):1910-5. View

4.
Renner W, Nauck M, Winkelmann B, Hoffmann M, Scharnagl H, Mayer V . Association of angiotensinogen haplotypes with angiotensinogen levels but not with blood pressure or coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health Study. J Mol Med (Berl). 2004; 83(3):235-9. DOI: 10.1007/s00109-004-0618-0. View

5.
Krizanova O, Obdrzalkova D, Polakova H, Jelok I, Hudecova S . Molecular variants of the renin-angiotensin system components in the Slovak population. Physiol Res. 1997; 46(5):357-61. View